| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46830b651781109964ac264c9d707376 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate |
1994-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18644a3aedd72624e81c4d39c4ca03f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9021a664336620d9b2656c794e24ee17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b67998005b56fd76479a17bc6b94329
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b63599e4f7adbc54d64c90f9e95d2977
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ffe148fbb82c8fd881c77c6c0825397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2bd30dd436cee1d5d65ed66908b4930 |
| publicationDate |
2007-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2154485-C |
| titleOfInvention |
Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |
| abstract |
A pharmaceutical composition, containing as active substance 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone of formula (I) and/or pharmaceutically acceptable salt thereof together with pharmaceutically acceptable carriers and optionally auxiliary agents and the use of 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone for the preparation of a medicament having central nervous system activities are disclosed. |
| priorityDate |
1993-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |